Arrivent BioPharma, Inc. (AVBP)
16.48
+0.02
(+0.12%)
USD |
NASDAQ |
Oct 13, 10:38
Arrivent BioPharma EPS Diluted (Quarterly) : -1.048 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.048 |
| March 31, 2026 | -0.9612 |
| December 31, 2025 | -0.8373 |
| September 30, 2025 | -0.8345 |
| June 30, 2025 | -0.897 |
| March 31, 2025 | -1.891 |
| December 31, 2024 | -0.6121 |
| September 30, 2024 | -0.6103 |
| Date | Value |
|---|---|
| June 30, 2024 | -0.6528 |
| March 31, 2024 | -0.52 |
| December 31, 2023 | -0.6327 |
| September 30, 2023 | -0.43 |
| June 30, 2023 | -0.6439 |
| March 31, 2023 | -0.3634 |
| December 31, 2022 | -0.3118 |
| September 30, 2022 | -0.3514 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -49.89M |
| Total Expenses (Quarterly) | 49.89M |
| Enterprise Value | 422.57M |
| Earnings Yield | -22.34% |
| Normalized Earnings Yield | -22.34 |